Akums Drugs and Pharmaceuticals Ltd - 544222 - Closure of Trading Window
Trading Window Closure06-08-2024
06-08-2024
Akums Drugs and Pharmaceuticals Ltd - 544222 - Listing of Equity Shares of Akums Drugs and Pharmaceuticals Ltd
Trading Members of the Exchange are hereby informed that effective from August 06, 2024, the equity shares of Akums Drugs and Pharmaceuticals Ltd (Scrip Code: 544222) are listed and admitted to dealings on the Exchange in the list of ''B'' Group Securities. For further details please refer to the notice no. 20240805 dated August 05, 2024.06-08-2024
Akums Drugs and Pharma's IPO gets fully-subscribed on Day 1 of offer
The initial public offer of Akums Drugs and Pharmaceuticals got fully-subscribed on the first day of subscription on Tuesday. The Rs 1,875-crore initial share sale received bids for 2,07,92,684 shares, as against 1,51,62,239 shares on offer, translating to 1.37 times subscription, as per the NSE data. The issue will conclude on August 1. The quota for Retail Individual Investors (RIIs) received 3.35 times subscription, while the Non Institutional Investors part got subscribed 1.96 times. The portion for qualified institutional buyers (QIBs) received 43 per cent subscription. The IPO is a combination of a fresh issue of equity shares worth Rs 680 crore and an offer-for-sale (OFS) of 1.73 crore shares valued at Rs 1,177 crore at the upper-end of the price band by promoters and an existing investor. Those selling shares in the OFS are Sanjeev Jain, Sandeep Jain and Ruby QC Investment Holdings Pte Ltd. The public issue has a price range of Rs 646 to Rs 679 per share Akums Drugs and31-07-2024